RIGL
Rigel Pharmaceuticals IncCompany with tickers: RIGL
Market Cap
$710.48M
Shares Outstanding
18,502,080
CIK
1034842
CUSIP
766559702
13F Activity (30d)
2 filings
2 filers
Website
Visit website
Investor Relations
Investor relations
Press releases and events scraped from the company's investor relations website. News and event listings link back to the original source.
Past events
| Date | Event | Type |
|---|---|---|
| 2026-06-16 | June 2026 Corporate Presentation | Presentation |
| 2026-06-03 | Jefferies Global Healthcare Conference | Conference |
| 2026-05-19 | 2026 RBC Capital Markets Global Healthcare Conference | Conference |
| 2026-05-14 | 2026 Annual Meeting of Stockholders | Shareholder meeting |
| 2026-05-12 | Rigel Pharmaceuticals, Inc. VEPPANU (vepdegestrant) Licensing Agreement Conference Call | Conference |
| 2026-05-05 | First Quarter 2026 Financial Results | Event |
Source: https://www.rigel.com/investors